The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Petriy V.V.

Treatment and Rehabilitation Center

Maksimkin D.A.

Peoples’ Friendship University of Russia

Shugushev Z.Kh.

Peoples’ Friendship University of Russia

Features of atrial fibrillation treatment in a patient with high risk of thromboembolic complications receiving oral anticoagulation

Authors:

Petriy V.V., Maksimkin D.A., Shugushev Z.Kh.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6): 637‑641

DOI: 10.17116/kardio202215061637

Views: 1800

Downloaded: 30

Download PDF (RU)
Contact the author
Table of contents

FEATURES OF ATRIAL FIBRILLATION TREATMENT IN A PATIENT WITH HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS RECEIVING ORAL ANTICOAGULATION
FEATURES OF ATRIAL FIBRILLATION TREATMENT IN A PATIENT WITH HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS RECEIVING ORAL ANTICOAGULATION

To cite this article:

Petriy VV, Maksimkin DA, Petriy VV, Shugushev ZKh. Features of atrial fibrillation treatment in a patient with high risk of thromboembolic complications receiving oral anticoagulation. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):637‑641. (In Russ.)
https://doi.org/10.17116/kardio202215061637

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Close metadata
Recommended articles:
In-hospital resu­lts of thoracoscopic box-lesion radiofrequency left atrial abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):483-488
A modi­fied method of left atrial radiofrequency abla­tion for atrial fibrillation in a patient unde­rgoing mitral valve replacement under warm blood cardioplegia. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):556-560
Venous Thro­mboembolism in Women with Chro­nic Venous Disease of the Lower Extremities Receiving Direct Oral Anti­coagulants for Atrial Fibrillation. Journal of Venous Diso­rders. 2024;(2):106-114
Venous Thro­mboembolism in Women with Chro­nic Venous Disease of the Lower Extremities Receiving Direct Oral Anti­coagulants for Atrial Fibrillation. Journal of Venous Diso­rders. 2024;(2):106-114
Evaluation of clinical effi­cacy and effi­ciency of new anti­coagulants and sodium-glucose cotransporter 2 inhi­bitors in patients with coro­nary artery disease and concomitant cardiovascular diseases. Medi­cal Technologies. Asse­ssment and Choice. 2024;(3):115-123
Anti­coagulant Therapy Flaws in Hospitalized Patients with Proximal Deep Vein Thro­mbosis and Their Impact on the Treatment Outcomes. Journal of Venous Diso­rders. 2024;(3):178-184
Risk Factors of Bleedings in Patients with COVID-19 Receiving Anti­coagulants for Venous Thro­mboembolism Prevention. Journal of Venous Diso­rders. 2024;(3):222-231
Atrial fibrillation and bleeding as complications of targeted therapy in chro­nic lymphocytic leukemia with impact on cardiovascular mortality. Russian Cardiology Bulletin. 2024;(3):16-25
The role of imba­lance of myocardial cell adhe­sion proteins in cardiac arrhythmia and heart failure. Russian Journal of Archive of Pathology. 2024;(5):75-80
Predictors of atrial fibrillation recu­rrence after biatrial cryo-maze procedure: a systematic review. Piro­gov Russian Journal of Surgery. 2024;(11):100-104

We present a patient with atrial fibrillation and thromboembolic complications manifested by thrombosis of the left atrial appendage while taking oral anticoagulation (rivaroxaban 20 mg), as well as recurrent ischemic cerebrovascular accidents (dabigatran 150 mg 2 times per day). The left atrial appendage was successfully occluded in this patient, and low molecular weight heparin was administered (enoxaparin 80 mg per day) for 45 days. Considering additional risk factors of thromboembolic complications (residual blood flow 5 mm, reduced left ventricular ejection fraction and increased D-dimer), we continued anticoagulation that prevented thromboembolic complications in long-term follow-up period.

Keywords:

atrial fibrillation
left atrial appendage occlusion
left atrial appendage occluder
anticoagulation
thromboembolic events

Authors:

Petriy V.V.

Treatment and Rehabilitation Center

Maksimkin D.A.

Peoples’ Friendship University of Russia

Shugushev Z.Kh.

Peoples’ Friendship University of Russia

Received:

17.11.2021

Accepted:

10.05.2022

List of references:

  1. Rodriguez CJ, Soliman EZ, Alonso A, et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol. 2015;25:71-76.  https://doi.org/10.1016/j.annepidem.2014.11.024
  2. Weng LC, Preis SR, Hulme OL, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation. 2018;137:1027-1038. https://doi.org/10.1161/CIRCULATIONAHA.117.031431
  3. Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501-1508. https://doi.org/10.1161/CIRCULATIONAHA.110.009035
  4. Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142-1147. https://doi.org/10.1016/j.amjcard.2013.05.063
  5. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746-2751. https://doi.org/10.1093/eurheartj/eht280
  6. Andrew NE, Thrift AG, Cadilhac DA. The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made? Neuroepidemiology. 2013;40:227-239.  https://doi.org/10.1159/000343667
  7. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955962. https://doi.org/10.1016/S0140-6736(13)62343-0
  8. Johnsen SP, Dalby LW, Täckström T, et al. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017;17:714.  https://doi.org/10.1186/s12913-017-2652-y
  9. Hylek EM, Held C, Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014;63(20):2141-2147. https://doi.org/10.1016/j.jacc.2014.02.549
  10. Steinberg BA, Greiner MA, Hammill BG, et al. Contraindications to anticoagulation therapy and eligibility for novel anticoagulation in older patients with atrial fibrillation. Cardiovasc Ther. 2015;33:177-183.  https://doi.org/10.1111/1755-5922.12129
  11. van den Heuvel JM, Hövels AM, Büller HR, et al. NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands. Thromb J. 2018;16:7.  https://doi.org/10.1186/s12959-017-0156-y
  12. Beinart R, Heist EK, Newell JB, et al. Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(1):10-15.  https://doi.org/10.1111/j.1540-8167.2010.01854.x
  13. Lee JM, Seo J, Uhm JS, et al. Why Is Left Atrial Appendage Morphology Related to Strokes? An Analysis of the Flow Velocity and Orifice Size of the Left Atrial Appendage. Journal of Cardiovascular Electrophysiology. 2015;26(9):922-927.  https://doi.org/10.1111/jce.12710
  14. Di Biase L, Santangeli P, Anselmino M, et al. Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation? Results From a Multicenter Study. Journal of American College of Cardiology. 2012;60:531-538.  https://doi.org/10.1016/j.jacc.2012.04.032
  15. Freeman JV, Varosy P, Price MJ, et al. The NCDR Left Atrial Appendage Occlusion Registry. Journal of the American College of Cardiology. 2020;75(13):1503-1518. https://doi.org/10.1016/j.jacc.2019.12.040
  16. Wan H, Wu S, Yang Y, et al. Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis. PLoS One. 2017;12(2):e0172272. https://doi.org/10.1371/journal.pone.0172272
  17. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020;00:1-125.  https://doi.org/10.1093/eurheartj/ehaa612
  18. Albaghdadi M, Kadlec A, Adler A, et al. Peri-Device Leaks after Percutaneous Left Atrial Appendage Closure: Clinical Significance and Unmet Diagnostic Needs. Structural Heart. 2020;4(6):475-481.  https://doi.org/10.1080/24748706.2020.1817642

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.